Location: Home
  • search
  • go
  • Relate News
  • 6/25/2018CDE Publishes Interim General Technical Requirements for Batch Product...
  • 6/25/2018Recent Executive Moves
  • 6/25/2018Global Times: India Must Boost Innovation to Benefit from China's Open...
  • 6/25/2018WuXi Biologics and Harbour BioMed Announce Strategic Partnership
  • 6/22/2018Tot Biopharm Opens New Biologics Facility in Suzhou
  • 6/22/2018Pacira Pharma and Nuance Biotech Announce License Agreement for EXPARE...
  • 6/22/2018CASI Pharma Enters Agreement With Yiling Wanzhou for Entecavir and Cil...
  • 6/21/2018China's Removal of Imported Drug Tariffs: Implications for Foreign and...
  • 6/21/2018State Council Makes Decisions on Registration of Foreign New Drugs, Pr...
  • 6/20/2018Wuxi Biologics Initiated Construction of Integrated ADC Solution Cente...
  • 6/20/2018Cipla Reportedly in Talks with Desano for A Majority-owned Chinese JV
  • 6/20/2018IQVia: Overview of Urban Chinese Hospital Drug Sales in 2017
  • 6/20/2018IQVia: Overview of Chinese Urban Retail Pharmacy Market in 2017
  • 6/20/2018Upcoming Event: Shanghai eHealth Workshop
  • 6/20/2018Overview of Chinese In-licensing of Foreign Investigational New Drugs ...
  • 6/20/2018China's Antibiotic Consumption Lowered in 2017
  • 6/20/2018Pacira and Nuance Bio Announce License Agreement for Exparel in China
  • 6/20/2018MSF Challenges Gilead's Chinese Patent HCV Drug Velpatasvir
  • 6/20/2018European Chamber Warns China over Uneven Market Access and Treatment f...
  • 6/20/2018Sedor and Los Altos Enter Greater China License Agreement for CE-Melox...
  • 6/20/2018Luye Pharma's Class 1.1 New Analgesic to Start Phase I Trial in China
  • 6/19/2018Merck and Alibaba Health Announce Collaboration to Develop Patient-Cen...
  • 6/19/2018Johnson & Johnson Launches J&J Institute for Asia Pacific Regi...
  • 6/19/2018Stealth Bio Announces $100M Financing to Advance Development of Elamip...
  • 6/19/2018Alpha Biopharma Announces Series A Financing
  • 6/19/2018MNCs Lose Top Talents to Booming Domestic Biopharma Startups
  • 6/19/2018CITIC Capital Proposes To Acquire China Biologic for $3.65B
  • 6/19/2018India Releases Study for Enhancing Access to the Chinese Pharma Market
  • 6/15/2018China Adds Jinan and Changsha Airports as Drug Import Destination Port...
  • 6/15/2018Recent Official and Executive Moves
  • Page:319/774 Total number of articles:23207: [First][<<] [317] [318] [319] [320] [321] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group